The companies' monoclonal antibody met co-primary endpoints in a Phase III trial in patients with chronic rhinosinusitis with nasal polyps.
Phalguni Deswal is a journalist who specializes in the medical and pharmaceutical industries. With a focus on medical devices, clinical trials, and pharmaceutical advancements, Phalguni's articles provide insights into the latest developments in the healthcare sector. With contributions to publications such as Medical Device Network, Pharmaceutical-Technology, and Clinical Trials Arena, Phalguni keeps readers informed about the latest advancements and breakthroughs in the field.